User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease?

Primary tabs

Legry, Vanessa [UCL] Schaap, Franck G [Maastricht University] Delire, Bénédicte [UCL] Horsmans, Yves [UCL] Leclercq, Isabelle [UCL]
Document type Article de périodique (Journal article) – Éditorial
Access type Accès restreint
Publication date 2014
Language Anglais
Journal information "Gut" - Vol. 63, no. 1, p. 1-2
Peer reviewed yes
Publisher B M J Group ((United Kingdom) [S.l.])
issn 0017-5749
e-issn 1468-3288
Publication status Publié
Affiliations UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - (SLuc) Service d'hépato-gastro-entérologie
Links
  1. Chalasani Naga, Younossi Zobair, Lavine Joel E., Diehl Anna Mae, Brunt Elizabeth M., Cusi Kenneth, Charlton Michael, Sanyal Arun J., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, 10.1002/hep.25762
  2. Tilg Herbert, Moschen Alexander R., Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis, 10.1002/hep.24001
  3. Hollman Danielle A.A., Milona Alexandra, van Erpecum Karel J., van Mil Saskia W.C., Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms, 10.1016/j.bbalip.2012.07.004
  4. Sanyal, Hepatology, 50, 389A (2009)
  5. Cipriani Sabrina, Mencarelli Andrea, Palladino Giuseppe, Fiorucci Stefano, FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats, 10.1194/jlr.m001602
  6. Uriarte Iker, Fernandez-Barrena Maite G, Monte Maria J, Latasa Maria U, Chang Haisul C Y, Carotti Simone, Vespasiani-Gentilucci Umberto, Morini Sergio, Vicente Eva, Concepcion Axel R, Medina Juan F, Marin José Juan G, Berasain Carmen, Prieto Jesus, Avila Matías A, Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice, 10.1136/gutjnl-2012-302945
  7. Fuchs Michael, Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target, 10.1155/2012/934396
  8. Blättler Sharon M., Cunningham John T., Verdeguer Francisco, Chim Helen, Haas Wilhelm, Liu Huifei, Romanino Klaas, Rüegg Markus A., Gygi Steven P., Shi Yang, Puigserver Pere, Yin Yang 1 Deficiency in Skeletal Muscle Protects against Rapamycin-Induced Diabetic-like Symptoms through Activation of Insulin/IGF Signaling, 10.1016/j.cmet.2012.03.008
  9. Cunningham John T., Rodgers Joseph T., Arlow Daniel H., Vazquez Francisca, Mootha Vamsi K., Puigserver Pere, mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex, 10.1038/nature06322
  10. Gordon S, Akopyan G, Garban H, Bonavida B, Transcription factor YY1: structure, function, and therapeutic implications in cancer biology, 10.1038/sj.onc.1209080
  11. Lu Yan, Ma Zhimin, Zhang Zhijian, Xiong Xuelian, Wang Xiaolin, Zhang Huijie, Shi Guojun, Xia Xuefeng, Ning Guang, Li Xiaoying, Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice, 10.1136/gutjnl-2012-303150
  12. Leclercq, Emerging concepts on pathogenesis of NASH. Non-alcoholic fatty liver disease: a practical guide (2013)
  13. Ma K., Farnesoid X receptor is essential for normal glucose homeostasis, 10.1172/jci25604
  14. Kir S., Beddow S. A., Samuel V. T., Miller P., Previs S. F., Suino-Powell K., Xu H. E., Shulman G. I., Kliewer S. A., Mangelsdorf D. J., FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis, 10.1126/science.1198363
  15. Shin Dong-Ju, Osborne Timothy F., FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action, 10.1074/jbc.m808747200
  16. Jones Stacey, Mini-Review: Endocrine Actions of Fibroblast Growth Factor 19, 10.1021/mp700105z
  17. Kim Insook, Ahn Sung-Hoon, Inagaki Takeshi, Choi Mihwa, Ito Shinji, Guo Grace L., Kliewer Steven A., Gonzalez Frank J., Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine, 10.1194/jlr.m700330-jlr200
  18. Cariou Bertrand, van Harmelen Kirsten, Duran-Sandoval Daniel, van Dijk Theo H., Grefhorst Aldo, Abdelkarim Mouaadh, Caron Sandrine, Torpier Gérard, Fruchart Jean-Charles, Gonzalez Frank J, Kuipers Folkert, Staels Bart, The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice, 10.1074/jbc.m510258200
  19. Sinal Christopher J, Tohkin Masahiro, Miyata Masaaki, Ward Jerrold M, Lambert Gilles, Gonzalez Frank J, Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis, 10.1016/s0092-8674(00)00062-3
  20. Trauner Michael, Halilbasic Emina, Nuclear Receptors as New Perspective for the Management of Liver Diseases, 10.1053/j.gastro.2011.02.044
Bibliographic reference Legry, Vanessa ; Schaap, Franck G ; Delire, Bénédicte ; Horsmans, Yves ; Leclercq, Isabelle. Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease?. In: Gut, Vol. 63, no. 1, p. 1-2
Permanent URL http://hdl.handle.net/2078.1/128248